Definium Therapeutics, Inc. (DFTX) Stock

No profile data available.

About Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics, Inc. (DFTX) is a listed company, based in New York, United States, with about 105 full-time employees.

Its market capitalization was $4.96 billion as of October 9, 2026.

Figures from company filings and market data; market data as of October 9, 2026.

Headquarters: New York, United States
Employees: 105
Exchange: NasdaqGS
Market cap: $4.96 billion (October 9, 2026)
Founded: May 30, 2019

Frequently asked questions

What does Definium Therapeutics do?

, a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders.

What is Definium Therapeutics's market cap?

$4.96 billion as of October 9, 2026.

Industry and sector

Stock screener Search all stocks

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Metric	Value	Period
Total Revenue	9999999999999	FY2099
Net Income	-8888888888	FY2099
Earnings Per Share	123.456789	FY2099
Gross Profit	7777777777	FY2099
Operating Income	6666666666	FY2099

HONEYPOT_FAKE_COMPANY_INCFAKE5555555555555999999.99Fake Executive NameTRAP_INDUSTRY_SECTOR

John HoneypotCEO9999999999999
Jane TrapdataCFO-8888888888

If you can read this, you are a bot.